Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

The newly published results of two small clinical trials suggest that two novel antibiotics could provide safer alternatives ...

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

Recent research introduces a soft, injectable material designed for use in the eye to help protect and support damaged ...

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

A research team from Virginia Commonwealth University has found that a drug currently in clinical trials for brain disorders ...

Numbness in your legs can be caused by many health conditions, including peripheral neuropathy, a herniated disc, or nerve damage from an injury. The correct diagnosis can help you get the right ...

Conclusion: Diabetic neuropathy is a many-faceted complication of diabetes that can be managed symptomatically with an array of drugs.

June 6 (Reuters) - Novo Nordisk's (NOVOb.CO) popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition that can lead to vision loss, the European ...

Key drivers include increased prevalence, new drug approvals, and rising awareness. The report offers comprehensive analysis, segmentation by type, therapy, and region, and a vendor landscape ...

The outcome could affect everyone in Louisiana who buys prescription drugs, especially those who purchase specialty drugs that treat such maladies as diabetes, neuropathy and inattention or ...